Value Partners Investments Inc. Has $848,000 Stock Position in Danaher Corporation $DHR

Value Partners Investments Inc. increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 57.2% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 4,297 shares of the conglomerate’s stock after acquiring an additional 1,563 shares during the quarter. Value Partners Investments Inc.’s holdings in Danaher were worth $848,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Hills Bank & Trust Co raised its position in shares of Danaher by 0.3% during the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate’s stock worth $3,693,000 after purchasing an additional 53 shares during the period. Sageworth Trust Co raised its holdings in Danaher by 2.3% during the 1st quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate’s stock worth $493,000 after buying an additional 54 shares during the period. 1834 Investment Advisors Co. lifted its stake in Danaher by 3.3% in the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate’s stock valued at $342,000 after buying an additional 54 shares in the last quarter. Rakuten Securities Inc. boosted its holdings in shares of Danaher by 33.3% in the first quarter. Rakuten Securities Inc. now owns 224 shares of the conglomerate’s stock valued at $46,000 after buying an additional 56 shares during the period. Finally, Kingswood Wealth Advisors LLC raised its holdings in shares of Danaher by 1.6% during the first quarter. Kingswood Wealth Advisors LLC now owns 3,466 shares of the conglomerate’s stock worth $710,000 after acquiring an additional 56 shares during the period. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of DHR stock opened at $190.07 on Friday. The company has a fifty day moving average price of $201.21 and a two-hundred day moving average price of $198.83. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The stock has a market cap of $136.10 billion, a P/E ratio of 40.44, a P/E/G ratio of 2.72 and a beta of 0.75. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same period in the prior year, the firm earned $1.72 EPS. Danaher’s quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Analysts Set New Price Targets

Several research firms have issued reports on DHR. Wells Fargo & Company dropped their price target on Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research note on Wednesday, July 23rd. Guggenheim reaffirmed a “buy” rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a research report on Tuesday, September 2nd. UBS Group lowered their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research note on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Seventeen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $246.35.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the business’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares of the company’s stock, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.